AQST - Aquestive Therapeutics Inc. (AQST) CEO Keith Kendall on Q1 2019 Results - Earnings Call Transcript
Aquestive Therapeutics, Inc. (NASDAQ:AQST)
Q1 2019 Earnings Conference Call
May 8, 2019 8:00 AM ET
Company Participants
Lauren Walrath - Head, Corporate Marketing and Communications
Keith Kendall - Chief Executive Officer
Ken Marshall - Chief Commercial Officer
Daniel Barber - Chief Strategy and Development Officer
John Maxwell - Chief Financial Officer
Conference Call Participants
Randall Stanicky - RBC Capital Markets
Liana Moussatos - Wedbush Securities
Thomas Flaten - Lake Street Capital
Ram Selvaraju - H.C. WainWright
Presentation
Operator
Good morning, and welcome to the Aquestive Therapeutics First Quarter 2019 Conference Call. At this time, all